Marcus Karia

Group Finance Director, London, UK

Marcus is the Group Finance Director of Arix Bioscience. He works across all aspects of Arix’s operations and oversees finance, portfolio monitoring and analysis and IT.

Marcus joined the company soon after inception in 2016, leading the development of the group’s operations, as well as supporting Arix through its IPO. He sits on the board of Arix Capital Management, Arix’s regulated investment management subsidiary.

Marcus has worked in venture capital and private equity throughout his career. After qualifying as a Chartered Accountant with PricewaterhouseCoopers, he held positions at LDC, the private equity arm of Lloyds Bank, and Bridges Fund Management, a leading impact investor.

Marcus holds a First-Class degree in Economics from the University of Nottingham and is a member of the Institute of Chartered Accountants in England and Wales.